Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mesenchymal Stem Cell (MSC) by Cell Energy Life Sciences Group for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
Mesenchymal Stem Cell (MSC) is under clinical development by Cell Energy Life Sciences Group and currently in Phase II for...
Data Insights
Mesenchymal Stem Cell (MSC) by Cell Energy Life Sciences Group for Lung Injury: Likelihood of Approval
Mesenchymal Stem Cell (MSC) is under clinical development by Cell Energy Life Sciences Group and currently in Phase II for...